Skip to content

DEBAIZE, Stéphane Docteur

Active
Private limited companyfounded 20224 yrs activeCarloodreef 10, 1180 Ukkel, BelgiumKBO/BCE: BE 0790.614.435

The computed 12-month bankruptcy probability of DEBAIZE, Stéphane Docteur is 7.0% (elevated). The 2024 annual accounts show equity of €28k and a net result of €-2k. Equity is growing by ~31.6% per year across the filed fiscal years. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
53 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability13▼-87
Solvency94▼-6
Growth52▼-26
Track record94
Bankruptcy probability, 12 months
7.0% Elevated
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days only on tighter terms
Liquidity ample (current ratio 2.6 against 4.4 in 2023; short-term debt: 30.7% and cash: 79.8% of total assets), and 30.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
69.3%
Return on assets
-4.9%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 16-06-2025, 45 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
not confirmed
2024
45 d early
2023
40 d early
2022
48 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€28k▼ 6.6%
2023 · €30k
2022: €10k 2023: €30k
2022 → 2024
Total assets
€40k▲ 4.3%
2023 · €38k
2022: €22k 2023: €38k
2022 → 2024
Net result
€-2k
2023 · €20k
2022: €6k 2023: €20k
2022 → 2024
Working capital
€20k▼ 33.6%
2023 · €30k
2022: €10k 2023: €30k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202220232024Trend
Equity€10k-€30k▲ 191%€28k▼ 6.6%
Operating result€8k-€25k▲ 216%€-1k
Net result€6k-€20k▲ 213%€-2k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-10k€0€10k€20k€30kOperating result 2022: €8k€8kNet result 2022: €6k€6kOperating result 2023: €25k€25kNet result 2023: €20k€20kOperating result 2024: €-1k€-1kNet result 2024: €-2k€-2k202220232024
The operating result turns negative in 2024: a loss of €1k after €25k in 2023, the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €40k
Fixed assets €8k▲ 8,808%
Current assets €32k▼ 16.5%
Equity and liabilities €40k
Equity €28k▼ 6.6%
Debt €12k▲ 41.5%
The debt ratio rises from 22.7% to 30.7%. Equity is lower and debt is higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€-88
Cash flow
€-719
Solvency
69.3%
2023 · 77.3%
Current ratio
2.60
2023 · 4.40
Quick ratio
2.60
2023 · 4.40
Debt / equity
0.44
2023 · 0.29
ROE
-7.1%
2023 · 65.6%
ROA
-4.9%
2023 · 50.7%
Interest coverage
-1.95
Debt
€12k
2023 · €9k
Debt ≤ 1 year
€12k
2023 · €9k
Income taxes
€592
2023 · €6k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€38k€40k
Fixed assets21/28€91€8k
Tangible fixed assets22/27-€8k
Plant, machinery and equipment23-€4k
Furniture and vehicles24-€4k
Financial fixed assets28€91€91=
Current assets29/58€38k€32k
Cash at bank and in hand54/58€38k€32k
Equity and liabilities
Total equity and liabilities10/49€38k€40k
Equity10/15€30k€28k
Contributions10/11€4k€4k=
Reserves13€26k€24k
Distributable reserves133€26k€24k
Amounts payable17/49€9k€12k
Amounts payable within one year42/48€9k€12k
Trade debts44€570€7k
Suppliers440/4€570€7k
Taxes, remuneration and social security45€8k€6k
Taxes450/3€6k€592
Remuneration and social security454/9€2k€5k
Other amounts payable47/48-€0
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€1k
Other operating charges640/8€402€1k
Gross operating margin9900€26k€986
Operating profit (loss)9901€25k€-1k
Financial income75/76B-€5
Recurring financial income75-€5
Financial charges65/66B€11€45
Recurring financial charges65€11€45
Profit (loss) for the period before taxes9903€25k€-1k
Income taxes67/77€6k€592
Profit (loss) for the period9904€20k€-2k
Profit (loss) for the period to be appropriated9905€20k€-2k
Appropriation of the result
Profit (loss) to be appropriated9906€20k€-2k
Transfer from equity791/2-€2k
Transfer to equity691/2€20k-
To other reserves6921€20k-

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
16-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Weakest financial yearnet €-2k ▼110%
Net result drops to €-2k, the lowest in the series.
21-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Highest result since 2022net €20k ▲213%
Operating result €25k, net result €20k, both a record.
31-12
Financial Liquidity doublescurrent ratio 4.40
Current ratio from 1.85 to 4.40; short-term debt falls from €12k to €9k.
13-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2022
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Carloodreef 101180 Ukkel
Ground area
133 m²
Building footprint
133 m²
Volume, LiDAR
1,005 m³
Parcel 21614H0005/00Z033, Brussels · tallest building 11.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
DEBAIZE, Stéphane Docteur
Carloodreef 10, 1180 UkkelSpecialist medical practice
since 20222.335.926.086
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21614H0005/00Z033 Brussels 133 m² 1 · 133 m² 11.9 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded08-09-2022
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.